Navigation Links
Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Oramed's Oral Insulin Capsules
Date:7/7/2010

scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com.

Safe Harbor Statement

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical or biotechnology companies; and the company's ability to obtain additional funding required to conduct its research, development and commercialization activities. Please refer to the company's filings with the Securities and Exchange Commission for a comprehensive list of risk factors that could cause actual results, performance or achievements of the company to differ materially from those expressed or implied in such forward looking statements. The company undertakes no obligation to update or revise any forward-looking statements.

    Company and Investor Relation Contacts:
    Oramed Pharmaceuticals Inc.
    Tara Horn
    Office: +1-646-240-4193
    Cell: +972-54-334-4318
    Email: '/>"/>
SOURCE Oramed Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
2. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
3. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
4. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
5. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
6. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
7. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
8. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
9. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
10. Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)
11. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... , Sept. 29, 2014 Pharmaceutical Care Management ... today outlined policy solutions that could reduce prescription fraud ... Hill briefing, " Prescription Opioid Abuse: Fighting Back on ... Reform and PCMA. The briefing featured ... prescription drug abuse and fraud. The Centers for Disease ...
(Date:9/29/2014)... YORK , Sept. 29, 2014 ... Summary GlobalData,s new report, "EU5 Esophagoscopes ... market data on the EU5 Esophagoscopes & Gastroscopes ... US dollars, volume (in units) and average prices ... Video Esophagoscopes, Flexible Non-Video (Fibre) Gastroscopes and Flexible ...
(Date:9/29/2014)... BEIJING , Sept. 29, 2014  Following US and ... accelerator, the China Food and Drug Administration (CFDA) has ... in the country. According to the International ... people are diagnosed with cancer every year in ... types including lung, gastric, colorectal, liver and esophageal cancers ...
Breaking Medicine Technology:PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 3Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 2Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 3
... DIEGO, Dec. 18 Ambrx Inc. today announced ... with Merck & Co. Inc. to,develop a novel ... Factor 21 (FGF-21) for the treatment of type ... The collaboration utilizes Ambrx,s proprietary protein technology,ReCODE(TM), ...
... Epeius Biotechnologies,Corporation announced today that the company ... Rexin-G(R) from the Philippine Bureau of Food ... lead product as a safe,and effective treatment ... as a tumor-targeted anticancer agent, that actively ...
Cached Medicine Technology:Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc. 2ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 2ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 3
(Date:9/30/2014)... DC (PRWEB) September 30, ... **MEDIA ADVISORY** , From:        Hope ... Barnwell, 910.554.1505, abarnwell(at)hopeforthewarriors(dot)org ... Hope® Celebration , Date:        Thursday, ... Address:    The Army and Navy ...
(Date:9/30/2014)... Barbara Williamson shares her life story for the ... Life: Love, Sex and Commitment" . As co-founder with ... highly successful and controversial Sandstone Retreat in Malibu, California, ... started what became known as the hub of the ... outrageously popular, with a membership reaching 500 and nearly ...
(Date:9/30/2014)... 2014 Computer Resources of America, ... based in New York City, has been awarded ... to transform, manage, and support the IT environment ... a leading provider of innovative services that enable ... The contract will cover the four NY-metro ...
(Date:9/30/2014)... September 30, 2014 Bibliomotion is ... Redefining Leadership for the Complex Social Age by ... 2014). , In the book, the authors apply their leadership ... which to view the conversations, actions, and behaviors that leaders ... world. Click here to read a review of ...
(Date:9/30/2014)... 2014 RBS Reputation Management is reported to ... Your Name’. , The service name may surprise as ... the service this odd name, a management professional said, “This ... this name. We have named the service ‘Remove Your Name’ ... get rid of all those posts which light their name ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors' Got Heart, Give Hope Celebration Media Advisory 2Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 2Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 3Health News:CRA Awarded Managed Services Contract for Large NYC Nonprofit 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 3Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 4Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 5Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 6Health News:RBS Reputation Management Announces A New Service ‘Remove Your Name’ 2
... virus should be monitored for high blood pressure, expert ... Adults with the skin disease shingles appear to be ... the area around the eyes, researchers report. , Previous ... exact frequency and risk for these phenomena are still ...
... types of human papillomavirus (HPV), a sexually transmitted virus, ... Current guidelines prioritize HPV vaccination of pre-adolescent girls, which ... but the value of vaccinating boys in the United ... School of Public Health (HSPH) researchers found that if ...
... Study finds two-thirds of those with the mysterious illness infected ... About two-thirds of patients with chronic fatigue syndrome sampled in ... , The finding, albeit preliminary, has raised hopes that there ... thus, down the line, treatments for the disease. , "This ...
... Reportlinker.com announces that a new market research report ... Reportlinker Adds Germany Wound Care Management Market Analysis ... http://www.reportlinker.com/p0151443/Reportlinker-Adds-Germany-Wound-Care-Management-Market-Analysis-and-Forecasts-to-2015.html , ... Analysis and Forecasts to 2015 report provides key ...
... Biomonitoring Study Detects Four Chemicals from EPA,s Recently-Announced Top ... Physicians for Social Responsibility (PSR), American Nurses Association (ANA) ... Chemicals In Health Care," the first investigation of ... , Today,s announcement was made on a national teleconference ...
... cause of death worldwide. Our evolutionary struggle with this ... UC Riverside. Population geneticist Leonard Nunney will ... Struggle With Cancer," at 7 p.m., Thursday, Oct. 15, in ... p.m. Seating is open. "Cancer is unlike other diseases," ...
Cached Medicine News:Health News:Shingles Raises Stroke Risk: Study 2Health News:Shingles Raises Stroke Risk: Study 3Health News:Vaccinating boys against human papillomavirus not cost-effective 2Health News:Vaccinating boys against human papillomavirus not cost-effective 3Health News:Retrovirus May Be at Root of Chronic Fatigue Syndrome 2Health News:Retrovirus May Be at Root of Chronic Fatigue Syndrome 3Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 2Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 3Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 4Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 5Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 6Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 7Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 8Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 9Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 10Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 11Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 12Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 13Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 14Health News:Toxic Chemicals Found in Doctors and Nurses 2Health News:Evolutionary struggle with cancer is focus of public lecture at UC Riverside 2
Used for vascular access. Supplied sterile in peel-open packages. Intended for one-time use....
Used for placement of .035 inch (0.89 mm) or .038 inch (0.97 mm) diameter wire guides into the vascular system when a small 24 gage needle stick is desired....
Used to introduce large devices for vascular intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Medicine Products: